Patents by Inventor Sameer Shankar Walunj

Sameer Shankar Walunj has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURIFIED ARABINOGALACTAN-PROTEIN (AGP) COMPOSITION USEFUL IN THE TREATMENT PSORIASIS AND OTHER DISORDERS
    Publication number: 20090270330
    Abstract: A purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems of Argemone mexicana plant is described. Also described is a purified Arabinogalactan-Protein (AGP) composition isolated from the leaves and/or stems of Argemone mexicana plant, which has one or more of the following effects: immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFN-? inhibition, or IL-10 induction; keratinocyte proliferation inhibition, keratolytic activity and inhibitory activity in Mouse Ear Swelling test (MEST).
    Type: Application
    Filed: July 2, 2009
    Publication date: October 29, 2009
    Inventors: Sudershan Kumar ARORA, Vandita Srivastava, Sameer Shankar Walunj
  • PURIFIED ARABINOGALACTAN-PROTEIN (AGP) COMPOSITION USEFUL IN THE TREATMENT PSORIASIS AND OTHER DISORDERS
    Publication number: 20090264341
    Abstract: A purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems of Argemone mexicana plant is described. Also described is a purified Arabinogalactan-Protein (AGP) composition isolated from the leaves and/or stems of Argemone mexicana plant, which has one or more of the following effects: immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFN-? inhibition, or IL-10 induction; keratinocyte proliferation inhibition, keratolytic activity and inhibitory activity in Mouse Ear Swelling test (MEST).
    Type: Application
    Filed: July 2, 2009
    Publication date: October 22, 2009
    Inventors: Sudershan Kumar Arora, Vandita Srivastava, Sameer Shankar Walunj
  • Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
    Patent number: 7601368
    Abstract: A purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems of Argemone mexicana plant is described. Also described is a purified Arabinogalactan-Protein (AGP) composition isolated from the leaves and/or stems of Argemone mexicana plant, which has one or more of the following effects: immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFN-? inhibition, or IL-10 induction; keratinocyte proliferation inhibition, keratolytic activity and inhibitory activity in Mouse Ear Swelling test (MEST).
    Type: Grant
    Filed: September 1, 2004
    Date of Patent: October 13, 2009
    Assignee: Lupin Limited
    Inventors: Sudershan Kumar Arora, Vandita Srivastava, Sameer Shankar Walunj